Literature DB >> 29618290

Shared parameter models for joint analysis of longitudinal and survival data with left truncation due to delayed entry - Applications to cystic fibrosis.

Mark D Schluchter1, Annalisa V Piccorelli2.   

Abstract

Many longitudinal studies observe time to occurrence of a clinical event such as death, while also collecting serial measurements of one or more biomarkers that are predictive of the event, or are surrogate outcomes of interest. Joint modeling can be used to examine the relationship between the biomarker and the event, and also as a way of adjusting analyses of the biomarker for non-ignorable dropout. In settings such as registry studies, an additional complexity is caused when follow-up of subjects is delayed, referred to as left-truncation of follow-up in the survival analysis setting. If not adjusted for, this can cause bias in estimation of parameters of the survival distribution for the clinical event and in parameters of the longitudinal outcome such as the profile or rate of change over time because subjects may die or have the clinical event before follow-up starts. This paper illustrates how a broad class of shared parameter models can be used to jointly model a time to event outcome along with a longitudinal marker using available nonlinear mixed modeling software, when follow-up times are left truncated. Methods are applied to jointly model survival and decline in lung function in cystic fibrosis patients.

Entities:  

Keywords:  Joint modeling; accelerated failure time models; cystic fibrosis; longitudinal studies; non-ignorable dropout; nonlinear mixed models; piecewise exponential; proportional hazards models

Mesh:

Year:  2018        PMID: 29618290      PMCID: PMC6456442          DOI: 10.1177/0962280218764193

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  16 in total

1.  Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal disease.

Authors:  M D Schluchter; T Greene; G J Beck
Journal:  Stat Med       Date:  2001-04-15       Impact factor: 2.373

2.  Joint model with latent state for longitudinal and multistate data.

Authors:  E Dantan; P Joly; J-F Dartigues; H Jacqmin-Gadda
Journal:  Biostatistics       Date:  2011-03-17       Impact factor: 5.899

3.  A SAS macro for the joint modeling of longitudinal outcomes and multiple competing risk dropouts.

Authors:  Wei Wang; Wanmei Wang; Thomas H Mosley; Michael E Griswold
Journal:  Comput Methods Programs Biomed       Date:  2016-10-18       Impact factor: 5.428

4.  Lung function decline from adolescence to young adulthood in cystic fibrosis.

Authors:  Stacy L Vandenbranden; Ann McMullen; Michael S Schechter; David J Pasta; Rory L Michaelis; Michael W Konstan; Jeffrey S Wagener; Wayne J Morgan; Susanna A McColley
Journal:  Pediatr Pulmonol       Date:  2011-08-24

5.  Jointly modeling the relationship between longitudinal and survival data subject to left truncation with applications to cystic fibrosis.

Authors:  Annalisa V Piccorelli; Mark D Schluchter
Journal:  Stat Med       Date:  2012-07-11       Impact factor: 2.373

6.  A semiparametric approach to estimate rapid lung function decline in cystic fibrosis.

Authors:  Rhonda D Szczesniak; Gary L McPhail; Leo L Duan; Maurizio Macaluso; Raouf S Amin; John P Clancy
Journal:  Ann Epidemiol       Date:  2013-10-05       Impact factor: 3.797

7.  Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients.

Authors:  Mark D Schluchter; Michael W Konstan; Pamela B Davis
Journal:  Stat Med       Date:  2002-05-15       Impact factor: 2.373

8.  A comparison of change point models with application to longitudinal lung function measurements in children with cystic fibrosis.

Authors:  Angela Moss; E Juarez-Colunga; Farouk Nathoo; Brandie Wagner; Scott Sagel
Journal:  Stat Med       Date:  2016-01-05       Impact factor: 2.373

9.  Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study.

Authors:  David Taylor-Robinson; Margaret Whitehead; Finn Diderichsen; Hanne Vebert Olesen; Tania Pressler; Rosalind L Smyth; Peter Diggle
Journal:  Thorax       Date:  2012-05-03       Impact factor: 9.139

10.  Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification.

Authors:  Michael J Crowther; Therese M-L Andersson; Paul C Lambert; Keith R Abrams; Keith Humphreys
Journal:  Stat Med       Date:  2015-10-29       Impact factor: 2.373

View more
  3 in total

1.  Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral naive cohort: using a joint linear mixed and multistate Markov model.

Authors:  Zelalem G Dessie; Temesgen Zewotir; Henry Mwambi; Delia North
Journal:  BMC Infect Dis       Date:  2020-03-26       Impact factor: 3.090

2.  Flexible link functions in a joint hierarchical Gaussian process model.

Authors:  Weiji Su; Xia Wang; Rhonda D Szczesniak
Journal:  Biometrics       Date:  2020-05-28       Impact factor: 1.701

3.  Explaining the Sex Effect on Survival in Cystic Fibrosis: a Joint Modeling Study of UK Registry Data.

Authors:  David Taylor-Robinson; Daniela K Schlüter; Peter J Diggle; Jessica K Barrett
Journal:  Epidemiology       Date:  2020-11       Impact factor: 4.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.